During the past decade, Deawoong pharmaceutical conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Deawoong pharmaceutical" are "COVID-19 Patients" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Deawoong pharmaceutical" in a lesser frequency.

Most popular intervention types in "Deawoong pharmaceutical" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Anpl-one SR Tab. 300mg" (1 trials), "DWRX2003" (1 trials), "Placebo" (1 trials) and "Sarpodipil SR Tab. 300mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Deawoong pharmaceutical" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Deawoong pharmaceutical". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Deawoong pharmaceutical, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Deawoong pharmaceutical, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".